Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_assertion type Assertion NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_head.
- NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_assertion description "[Peripheral endocannabinoid overactivity might explain why CB(1) blockers cause weight-loss independent reduction of lipogenesis, of hypoadiponectinemia, and of hyperinsulinemia in obese animals and humans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_provenance.
- NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_assertion evidence source_evidence_literature NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_provenance.
- NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_assertion SIO_000772 16684820 NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_provenance.
- NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_assertion wasDerivedFrom befree-20140225 NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_provenance.
- NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_assertion wasGeneratedBy ECO_0000203 NP853132.RAXcSipEqMFW0SviTAgWhRPbPZIbv9epjY8HDLZltG3g0130_provenance.